Nephrology:中草药和膳食补充剂或与急性肾损伤相关

2015-11-23 徐媛 MedSci原创

本研究评估了使用中草药和膳食补充剂(HDS)与慢性肾疾病(CKD)之间的关系,及中草药和膳食补充剂(HDS)与CKD患者中不能控制的高磷血症之间的关系。 研究人员收纳了来自泰国的两个肾病诊所的3~5期CKD的406名患者,其中有357名患者随访12个月。接受肾替代治疗的患者被排除在外。通过调查问卷的形式了解患者HDS的使用情况,每天膳食摄入情况和常规的药物依从性。主要结局是肾小球滤过率至少降低5

本研究评估了使用中草药和膳食补充剂(HDS)与慢性肾疾病(CKD)之间的关系,及中草药和膳食补充剂(HDS)与CKD患者中不能控制的高磷血症之间的关系。

研究人员收纳了来自泰国的两个肾病诊所的3~5期CKD的406名患者,其中有357名患者随访12个月。接受肾替代治疗的患者被排除在外。通过调查问卷的形式了解患者HDS的使用情况,每天膳食摄入情况和常规的药物依从性。主要结局是肾小球滤过率至少降低5ml/分/1.73m2/年和终末期肾病。从患者的医疗记录中提取12个月的血清肌酐水平、血清钾水平和磷酸盐水平。卡方检验和多重逻辑回归分析来确定他们之间的关联性。

尽管在HDS与1年期间CKD进展之间无相关性(OR,1.16;95% CI,0.66~2.03),但有2名患者患有急性肾损伤,可能与未知的中草药或病历记录中报道的河紫鸭跖草联合双氯芬酸有关。使用中草药和膳食补充剂(HDS)与不能控制的高磷血症具有相关性(OR,3.53;95% CI,1.20~10.43)。

结果表明,HDS可能与急性肾损伤相关,而与CKD的进展不相关。这类产品与高磷血症之间存在相关性。我们应该密切关注使用中草药和膳食补充剂的CKD患者的肾功能和电解质。

原始出处

Tangkiatkumjai M1, Boardman H2, Praditpornsilpa K3, Walker DM1.Association of herbal and dietary supplements with progression and complications of chronic kidney disease: a prospective cohort study.Nephrology (Carlton). 2015 Jun 4.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2018-03-15 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2016-04-15 zll0637
  4. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2015-11-25 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=296341, encodeId=ff772963416c, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 15 06:05:35 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695664, encodeId=f14e1695664e2, content=<a href='/topic/show?id=89268592854' target=_blank style='color:#2F92EE;'>#膳食补充剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85928, encryptionId=89268592854, topicName=膳食补充剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5ef29855394, createdName=zsyan, createdTime=Thu Aug 04 13:59:00 CST 2016, time=2016-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754653, encodeId=83dd1e5465316, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Fri Apr 15 04:59:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350292, encodeId=44c91350292b8, content=<a href='/topic/show?id=224a85904ad' target=_blank style='color:#2F92EE;'>#膳食#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85904, encryptionId=224a85904ad, topicName=膳食)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396968, encodeId=de7b1396968d5, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Nov 25 07:59:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43600, encodeId=54ec43600c1, content=确实应该小心, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Nov 23 22:44:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2015-11-23 lovetcm

    确实应该小心

    0

相关资讯

JAMA:ICU患者使用生理盐水 vs 缓冲晶体溶液对急性肾损伤的影响

盐水(0.9%氯化钠)最常用于静脉输液给药;然而,它的使用可能与急性肾损伤(AKI)相关,并可能增加死亡率。该研究的目的是确定一种缓冲晶体溶液与生理盐水相比,对重症监护室(ICU)肾脏并发症的患者的影响。该双盲,随机,双交叉试验从2014年4月至2014年10月在新西兰4个ICU进行。三个ICU是一般的内科和外科ICU;1个ICU为心胸和血管外科。该研究的参与者为住进ICU,需要晶体液治疗的所有患

Lancet:中国急性肾损伤(AKI)现状,约占医院患者的1%

急性肾损伤 (AKI)是临床各科室最常见的急危重症之一。从轻微血肌酐升高到严重无尿性AKI,AKI程度和临床表现不一而足,AKI与患者病死率、慢性肾脏病(CKD)的发生以及维持性透析率密切相关。AKI现在已经成为全球公共健康问题之一

通过尿检评估急性肾损伤的风险

美国食品药品管理局(FDA; Silver Springs, MD, USA)的审核包括评估该检验安全性和有效性的两项临床研究。这两项研究将23家医院500多名危重症受试者的临床诊断与检验结果做了比较。一项研究中该检验准确检测出92%的AKI患者,另一项检验检测出76%的AKI患者。两项研究中,约半数无AKI的患者该检验得出的结果为阳性。市面上目前没有其它通过FDA认证的检验可供评估风险人群得AK

解汝娟:急性肾损伤的诊治进展

急性肾损伤(AKI)为多种原因造成的肾功能急性下降,是影响多器官、多系统的临床重症。近年来,有文献报告,轻至中度的肾功能受损即可引发严重临床后果,将肾脏病学界关注的重点由急性肾衰竭(ARF)进一步拓展至广义的损伤。 AKI占入院诊断的1%,7%以上的住院患者并发AKI,在发达国家其比例高达13%~18%;其中每年每百万人中有200例患者需要透析。随着年龄增长,AKI发病率升高,尤以80~

BMJ:新模型可预测骨科手术患者术后急性肾损伤的风险

急性肾损伤在骨科手术后的预测风险是什么?它是否会影响短期和长期的生存效果呢? 该队列由居住在苏格兰的国民保健服务泰赛德地区的从2005年1月1日到2011年12月31日之间接受整形外科手术的成人组成。该模型在6220例(两家医院)患者中被开发,并在第三家医院的4395例患者中进行外部验证。根据文献,临床专业知识,以及整形外科手术设置的可行性,术前几个变量被选定为候选预测。主要成果是术后第一周

Am Heart J :慢性肾脏疾病&急性肾损伤:对冠状动脉旁路移植术患者死亡率具有协同作用

韩国国立首尔大学医学院Seung Seok Han博士等人研究了慢性肾脏疾病(CKD)和急性肾损伤对于行冠状动脉旁路移植术患者死亡率之间的影响,谈论了两者对于GABG术后死亡率的影响,并不是相互排斥,而是相互协同的,其成果发表在3月份American heart journal期刊上。 背景:行冠状动脉旁路移植术(CABG)患者中,急性肾损伤(AKI)和慢性肾脏病(CKD)都是两个备受重视的